You are about to leave ViiVMedinfo.
By clicking "Allow," you will be taken to a website that is independent of ViiV Healthcare. The site you linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site.
With extensive experience in HIV specialty care and the HIV pharmaceutical industry, Dr. Kimberley Brown brings invaluable skills and background to ViiV Healthcare, with areas of expertise including HIV clinical practice, medical strategy and clinical development. She is committed to scientific excellence, ethical leadership and meaningful patient outcomes. Her mission is to bridge science and strategy to deliver innovative solutions that advance healthcare globally.
As ViiV’s Head of US Medical Affairs, Kimberley ensures medical integrity and oversight of ViiV initiatives, including developing medical strategies for ViiV therapies, leading development of ViiV-sponsored clinical research and investigator-sponsored research studies, overseeing ViiV product education, and providing medical input and oversight for the commercial organization.
Kimberley joined ViiV in 2023, serving as VP Global Medical Leader for Cabotegravir, leading a wide variety of initiatives to improve access, care and people development. Prior to that, she spent more than 15 years building her experience in infectious disease, especially HIV. She has served in field and in-house Medical Affairs and R&D leadership positions creating medical strategy for HIV, Hepatitis and Vaccines.
Kimberley obtained her Doctor of Pharmacy (PharmD) in 2003 from the University of North Carolina at Chapel Hill.
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at https://gsk.public.reportum.com or 1-877-844-8872, or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.
This site is intended for US Healthcare Professionals Only. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
Trademarks are owned by or licensed to the ViiV Healthcare group of companies.
©2025 ViiV Healthcare group of companies or its licensor. Produced in USA. February 2025